159 related articles for article (PubMed ID: 38713189)
1. Statins as an antineoplastic agent.
Raja HAA; Zulfiqar A; Abbasi AA; Arshad H; Nain P; Jaiswal V; Mattumpuram J
QJM; 2024 May; ():. PubMed ID: 38713189
[No Abstract] [Full Text] [Related]
2. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
[TBL] [Abstract][Full Text] [Related]
3. Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.
Costa IBSDS; Bittar CS; Fonseca SMR; E Silva CMPD; Dos Santos Rehder MHH; Rizk SI; Cruz CBBV; Figueiredo CS; de A Andrade FT; Barberino LA; de S Costa FA; Machado LP; González TB; Almeida MPC; Fukushima JT; Kalil Filho R; Hajjar LA
BMC Cardiovasc Disord; 2020 Apr; 20(1):206. PubMed ID: 32345217
[TBL] [Abstract][Full Text] [Related]
4. Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of Cardiology.
Nobre Menezes M; Tavares da Silva M; Magalhães A; Melica B; Toste JC; Calé R; Almeida M; Fiuza M; Infante de Oliveira E
Rev Port Cardiol; 2024 Jan; 43(1):35-48. PubMed ID: 37482119
[TBL] [Abstract][Full Text] [Related]
5. A cardio-oncology experience in Italy: results of a Tuscany regional-based survey.
Canale ML; Camerini A; Magnacca M; Casolo G;
J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):135-40. PubMed ID: 24553090
[TBL] [Abstract][Full Text] [Related]
6. [2022 ESC guidelines on cardio-oncology : Understanding and treating cardiovascular side effects from cancer therapy].
Michel L; Totzeck M; Rassaf T
Herz; 2023 Feb; 48(1):15-22. PubMed ID: 36441175
[TBL] [Abstract][Full Text] [Related]
7. The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology.
Fatunde OA; Brown SA
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963461
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular drug interventions in the cardio-oncology clinic by a cardiology pharmacist: ICOP-Pharm study.
Yaseen IF; Farhan HA
Front Cardiovasc Med; 2022; 9():972455. PubMed ID: 36247485
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Risk and Level of Statin Use Among Women With Breast Cancer in a Cardio-Oncology Clinic.
Shum K; Solivan A; Parto P; Polin N; Jahangir E
Ochsner J; 2016; 16(3):217-24. PubMed ID: 27660568
[TBL] [Abstract][Full Text] [Related]
10. Cardio-oncology: where do we stand for in Belgium?
Lancellotti P; De Pauw M; Claeys M
Acta Cardiol; 2021 Apr; 76(2):204-208. PubMed ID: 31967938
[TBL] [Abstract][Full Text] [Related]
11. Cardiac computed tomographic imaging in cardio-oncology: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT). Endorsed by the International Cardio-Oncology Society (ICOS).
Lopez-Mattei J; Yang EH; Baldassarre LA; Agha A; Blankstein R; Choi AD; Chen MY; Meyersohn N; Daly R; Slim A; Rochitte C; Blaha M; Whelton S; Dzaye O; Dent S; Milgrom S; Ky B; Iliescu C; Mamas MA; Ferencik M
J Cardiovasc Comput Tomogr; 2023; 17(1):66-83. PubMed ID: 36216699
[TBL] [Abstract][Full Text] [Related]
12. Intersecting care through specialized pharmacists: A case report of residency rotation focused on the new horizon of cardio-oncology.
Einsfeld L; do Canto Olegário I; Fagundes ML
Curr Pharm Teach Learn; 2023 May; 15(5):508-513. PubMed ID: 37183144
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles of microRNA-208a in cardiology and reverse cardio-oncology.
Wang X; Chen X; Xu H; Zhou S; Zheng Y; Keller BB; Cai L
Med Res Rev; 2021 Jul; 41(4):2172-2194. PubMed ID: 33533026
[TBL] [Abstract][Full Text] [Related]
14. Hypertension management in cardio-oncology.
Essa H; Dobson R; Wright D; Lip GYH
J Hum Hypertens; 2020 Oct; 34(10):673-681. PubMed ID: 32747676
[TBL] [Abstract][Full Text] [Related]
15. Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities.
Guha A; Armanious M; Fradley MG
Trends Cardiovasc Med; 2019 Jan; 29(1):29-39. PubMed ID: 29910109
[TBL] [Abstract][Full Text] [Related]
16. Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative.
Teske AJ; Moudgil R; López-Fernández T; Barac A; Brown SA; Deswal A; Neilan TG; Ganatra S; Abdel Qadir H; Menon V; Sverdlov AL; Cheng RK; Makhoul S; Ghosh AK; Szmit S; Zaha V; Addison D; Zhang L; Herrmann J; Chong JH; Agarwala V; Iakobishvili Z; Guerrero P; Yang EH; Leja M; Akhter N; Guha A; Okwuosa TM; Silva CC; Collier P; DeCara J; Bauer B; Lenneman CE; Sadler D
Circ Cardiovasc Qual Outcomes; 2023 Oct; 16(10):e009905. PubMed ID: 37702048
[TBL] [Abstract][Full Text] [Related]
17. Emergence of cardio-oncology.
Nebigil CG; Désaubry L
Ann Pharm Fr; 2018 Nov; 76(6):504-506. PubMed ID: 30075937
[TBL] [Abstract][Full Text] [Related]
18. Training and Career Development in Cardio-Oncology Translational and Implementation Science.
Brown SA; Yang EH; Branch M; Beavers C; Blaes A; Fradley MG; Cheng RK
Heart Fail Clin; 2022 Jul; 18(3):503-514. PubMed ID: 35718422
[TBL] [Abstract][Full Text] [Related]
19. Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology.
Kostakou PM; Kouris NT; Kostopoulos VS; Damaskos DS; Olympios CD
Heart Fail Rev; 2019 Jan; 24(1):91-100. PubMed ID: 30073443
[TBL] [Abstract][Full Text] [Related]
20. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
